Characterization of Patients with KRAS-Mutated Advanced Non-Small Cell Lung Cancer

C. C. Sousa (Porto, Portugal), J. Pinto (Porto, Portugal), N. Martins (Porto, Portugal), S. Teixeira (Braga, Portugal), A. Magalhães (Porto, Portugal), G. Fernandes (Porto, Portugal), V. Hespanhol (Porto, Portugal), H. Queiroga (Porto, Portugal), H. Novais Bastos (Porto, Portugal)

Source: International Congress 2019 – Thoracic oncology: Treatment, diagnostic options and biology
Session: Thoracic oncology: Treatment, diagnostic options and biology
Session type: Thematic Poster
Number: 4684

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. C. Sousa (Porto, Portugal), J. Pinto (Porto, Portugal), N. Martins (Porto, Portugal), S. Teixeira (Braga, Portugal), A. Magalhães (Porto, Portugal), G. Fernandes (Porto, Portugal), V. Hespanhol (Porto, Portugal), H. Queiroga (Porto, Portugal), H. Novais Bastos (Porto, Portugal). Characterization of Patients with KRAS-Mutated Advanced Non-Small Cell Lung Cancer. 4684

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: